Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

CDC provides COVID-19 vaccine best practices for healthcare providers

Image of Medical personnel filling a syringe from a vaccine bottle. Navy Hospitalman Milan Torres prepares a dose of the COVID-19 vaccine to be administered to a patient, Walter Reed National Military Medical Center, Bethesda, Maryland, Dec. 14, 2020. (Photo by Lisa Ferdinando, Office of the Secretary of Defense.)

Just days before an advisory committee of the Food and Drug Administration granted an emergency use authorization (EUA) to two manufacturers’ COVID-19 vaccine candidates, the Centers for Disease Control and Prevention prepared health care providers to handle the vaccine.

In parallel, the Defense Health Agency’s Immunization Healthcare Division (IHD) is working in collaboration with the CDC to offer the training to the Military Health System’s health care providers.

The training module provides health care providers information about the COVID-19 vaccine’s EUA, safety, storage, handling, administration, and reporting to assist them in administering COVID-19 vaccines safely and equitably. They’re also encouraged to follow their state, tribal, local, and territorial health officials’ guidance.

The module highlights that vaccine safety is a key element of every phase of development — from initial research, discovery, and pre-clinical trials; through the three phases of clinical trials, the FDA’s and Advisory Committee of Immunization Practices’ review, and the phase 4 post-approval safety monitoring and research process.

“The U.S. vaccine safety system ensures that all vaccines are as safe as possible,” says the CDC’s training module. “Safety is a top priority while federal partners work to make a COVID-19 vaccine available”.

Dr. Limone Collins, Jr., chief of IHD’s Vaccine Safety and Evaluation, which supported the Department of Defense-sponsored vaccine trials for the Astra-Zeneca candidate, highlighted that the FDA undertakes a very rigorous review of every product submitted to make sure that general precept is adhered to.

“They’re not going to let any product go through their review and analysis without giving that assurance to the U.S. population,” he said.

In addition to ensuring health care providers learn about the vaccines ahead of their approval for public distribution, the CDC scaled up an expanded network for safety surveillance in real time. Additional information sources and new technology for evaluation will give CDC and FDA the ability to monitor vaccine administration to ensure COVID-19 vaccines are safe.

For example, a new smartphone-based app, called V-SAFE, will use text messaging and web surveys from CDC to check in with vaccine recipients for any health problems following their vaccination. The app, together with CDC’s National Healthcare Safety Network — an acute care and long-term care facility monitoring system that reports to an existing vaccine event reporting system — and other FDA insurer/payer databases, comprise the broad network of monitoring systems in place for surveillance.

When FDA issues an EUA, it allows access to critical medical products that may help specifically during a public health emergency, according to the CDC’s training module. It is different from approval/licensure because it meets certain requirements that deem it for emergency use, such as that there is no adequate FDA-approved alternative available.

For health care providers, this means that a COVID-19 vaccine has been authorized for use according to the scope specified in a fact sheet like the package inserts for licensed vaccines. Additionally, health care providers must provide the fact sheet to vaccine recipients or their caregivers to communicate potential risks and benefits, vaccine administration data must be reported to CDC, and administration errors and specific and serious adverse events must be reported to the Vaccine Adverse Event Reporting Systems (VAERS) co-managed by the CDC and FDA. This includes cases of COVID-19 that result in hospitalization or death after the recipient has received a COVID-19 vaccine.

The training module also provides information such as a description of the COVID-19 disease; dosage and administration; storage and handling instructions; dose preparation and administration; requirements for use of the vaccine under EUA; risks and benefits, including any adverse events; any approved alternatives to prevent COVID-19; reporting requirements; and additional resources. This is done to ensure vaccine recipients are aware of all aspects of the experimental vaccine before its administration and to encourage them to monitor themselves post-vaccination, and report any significant events back to CDC for continuous research.

The training module also goes into detail about proper storage and handling of the vaccines, highlighting that failing to store and handle them properly could reduce their potency and result in “inadequate immune responses in patients and poor protection against the disease”. For example, their expiration and Beyond Use Date is an important step in the handling and storage process. Likewise, storing them at the recommended temperature is key, and any variation in that storage temperature, called a temperature excursion, should be noted and corrected immediately.

According to the information provided in the module, the nature of the COVID-19 pandemic underscores the importance of implementing standard infection prevention practices during vaccine administration by intramuscular injection. These include physical distancing, wearing the correct Personal Protective Equipment, respiratory and hand hygiene and surface decontamination, and source control.

Finally, the training module emphasized that COVID-19 vaccine products are not interchangeable, stating “the same product must be used for each dose in the vaccine series”. To manage this, healthcare providers will provide recipients personal vaccination cards so they’re aware of which vaccine product they received and when to schedule their next appointment to receive the second dose.

They will also provide each recipient or caregiver the EUA Fact Sheet for Recipients and V-SAFE information and encourage them to participate in the safety monitoring efforts as part of the phase 4 post-approval monitoring research. Health care providers will then record the date each dose was administered, the manufacturer and lot number, the vaccination site and route, and the name and title of the person administering the vaccine in their medical record systems as well as the patient’s medical record or immunization information system in order to report this data to each jurisdiction no later than 72 hours post-administration.

The Federal government has purchased COVID-19 vaccine and is making it available to the DOD for distribution and administration to DOD uniformed service members, both the active and Selected Reserve components, including members of the National Guard; dependents; retirees; civilian employees, and selected DoD contract personnel as authorized in accordance with DoD regulation.

The Department remains focused on protecting our Service members, DOD civilians, and families; safeguarding our national security capabilities; and supporting the whole-of-nation response to the COVID-19 pandemic.

You also may be interested in...

How COVID-19 Public Health Emergency’s End Affects TRICARE

Article Around MHS
5/16/2023
Immunization Clinic photo

The Public Health Emergency (PHE) for COVID-19 expired at the end of May 11. You might be wondering what this means about the state of COVID-19 or if there are changes to your TRICARE coverage.

COVID-19 Registry Provides Pandemic Response Insights, Optimizes Patient Care

Article
3/28/2023
COVID-19 Registry Provides Pandemic Response Insights, Optimizes Patient Care

Prior to the pandemic, the DOD began deploying MHS GENESIS, the new federal electronic health record, to improve health care outcomes for our service members, veterans, and their families. Critical enterprise needs quickly came to light to combat the impacts of the COVID-19 disease.

Navy’s Global Engagement Helps Identify and Mitigate Disease

Article
3/22/2023
Navy’s Global Engagement Helps Identify and Mitigate Disease

In support of the Military Health System, the Naval Medical Research Unit-2 is just one global entity that works with local partners to identify and combat global health threats.

Genome Sequencing Assists Research at Naval Health Research Center

Article
1/24/2023
Lab technicians doing genome research

Learn how unique samples from naval vessels, US-Mexico border populations, and DOD beneficiaries aided in the Naval Health Research Center’s sequencing efforts.

U.S. Military HIV Research Lends Lessons Learned to COVID-19

Article
1/19/2023
Gloved hands working in laboratory

The U.S. military has engaged in HIV research for three decades, contributing critical lessons learned, knowledge, and expertise during the COVID-19 research and vaccine development effort.

Naval Medical Research Center Uses Genome Sequencing for Variants

Article
1/12/2023
Military personnel pose for a group photo

NMRC’s efforts provided important support for sequencing and viral isolation to the Department of Defense and Military Health System.

USAMRIID Focuses on Genome Sequencing to Detect Variants

Article
1/5/2023
Military medical personnel in laboratory

A connected family of laboratories across the MHS allows a more rapid response to the outbreak.

Whole Genome Sequencing at Tripler Army Medical Center

Article
12/29/2022
Dr. Keith Fong reviews data with other lab technicians

The third installment in a 6-part series highlighting the efforts of the Military Health System laboratories and the technicians who worked to identify COVID-19 variants using special sequencing technology.

Walter Reed Army Institute of Research Implements SARS-CoV-2 Genome Sequencing

Article
12/23/2022
Military medical personnel in laboratory

This is the second article in a 6-part series that highlights the work of technicians and scientists in Military Health System laboratories who worked to identify COVID-19 variants using special sequencing technology.

Protect Yourself With Respiratory Illnesses on the Rise

Article Around MHS
12/19/2022
Military medical personnel administering vaccine

"Tis the season, and respiratory illnesses are on the rise. Learn critical health guidance about the viral triple threat of COVID-19, influenza, and the common cold, and the commonsense steps you can take to protect yourself and your family.

Military Labs Use Whole Genome Sequencing of COVID-19 Variants

Article
12/16/2022
Lab technician at work

The first in a 6-part series highlighting the work of technicians and scientists working in support of the MHS who identified COVID-19 variants using special sequencing technology.

DOD Reduces Health Care Waste by Reusing Crutches

Article
12/15/2022
Military personnel using crutches

When military facilities faced a national shortage of an essential mobility aid, they launched a grassroots initiative that not only ensured patient care, but also created a new waste reduction model within the DHA.

Flu Season’s Here: You Still Can Get Your Flu Shot for Protection

Article
12/12/2022
Flu Week Infographic

It’s not too late to get vaccinated against the flu and COVID-19.

MHS Minute | Nov 2022

Video
12/12/2022
MHS Minute | Nov 2022

The latest MHS Minute focuses on highlights from DHA Director Lt. Gen. Ronald J. Place’s final virtual town hall with the workforce, Nov. 16, 2022. The discussion included the agency’s biggest accomplishments over the past three years and the impact of COVID-19 on DHA’s reputation and approach to health care delivery.

Naval Medical Research Center Joint Study with Mount Sinai Uncovers Differences in COVID-19 Immune Response between the Sexes

Article Around MHS
12/5/2022
Amanda Cherry, research assistant, performing diagnostic testing at NMRC

A collaborative study between researchers at Naval Medical Research Center and the Icahn School of Medicine at Mount Sinai, and Princeton University has highlighted immune response differences in the coronavirus infection responses between male and female patients.

Page 1 of 25 , showing items 1 - 15
First < 1 2 3 4 5  ... > Last 
Refine your search
Last Updated: May 04, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery